Has Francois Haddad, MD received payments from drug or device companies?

Yes. Drug and device makers reported $22,611 in general payments to Francois Haddad, MD across 41 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Francois Haddad, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Francois Haddad, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Francois Haddad, MD

Advanced Heart Failure and Transplant Cardiology · Stanford, CANPI 1457493843

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $17,690 of the $22,611 with a category attached, or 78.2%. Merck accounts for 93.5% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2024 at $14,564 and has fallen 99.2% since, to $111 in 2025.

$22,611in general payments, 2019–2025

Across 41 payments — averaging $551.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$21K
Actelion Pharmaceuticals US, Inc.$1K
Medtronic$239
Janssen Research & Development, LLC$48

$501,562in research payments, 2019–2025

Across 13 payments — averaging $38,582 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Janssen Research & Development, LLC$502K

What the payments were for

Consulting fees$17,69078%
Travel & lodging$3,56816%
Food & beverage$1,3536%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	26	$21,145
Actelion Pharmaceuticals US, Inc.	12	$1,179
Medtronic	2	$239
Janssen Research & Development, LLC	1	$48

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,611 in reported general payments places this provider in the 65th percentile of 111 advanced heart failure and transplant cardiology providers in California.

See all advanced heart failure and transplant cardiology providers in California →

Medicare billing

Part B allowed, 2024

$158,352

Medicare patients

1,792

Services billed

2,531

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	67	$72,722
JardianceEmpagliflozin	53	$66,247
XareltoRivaroxaban	24	$31,598
EntrestoSacubitril/Valsartan	16	$15,275
Tacrolimus	60	$8,675
Sirolimus	15	$5,436
Amiodarone Hcl	22	$2,482
Rosuvastatin Calcium	118	$2,077
Mycophenolate Mofetil	27	$1,986
Bumetanide	46	$1,719
Eplerenone	15	$1,454
Metoprolol Succinate	77	$1,189
Carvedilol	91	$1,010
Spironolactone	109	$907
Bisoprolol Fumarate	18	$711

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in Stanford

Ronald WittelesStanford$251K
Jeffrey TeutebergStanford$195K
Kevin AlexanderStanford$125K
Eldrin LewisStanford$57K
Kiran KhushStanford$15K
Stephanie HsiaoStanford$12K
Richard WrightSanta Monica$1.7M
James Heywoodla Jolla$1.2M
Hirsch MehtaSan Diego$494K
Teresa de MarcoSan Francisco$366K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →